Jeanne Odom

1.5k total citations
27 papers, 1.1k citations indexed

About

Jeanne Odom is a scholar working on Hematology, Immunology and Genetics. According to data from OpenAlex, Jeanne Odom has authored 27 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Hematology, 10 papers in Immunology and 9 papers in Genetics. Recurrent topics in Jeanne Odom's work include Hematopoietic Stem Cell Transplantation (13 papers), Immune Cell Function and Interaction (9 papers) and T-cell and B-cell Immunology (8 papers). Jeanne Odom is often cited by papers focused on Hematopoietic Stem Cell Transplantation (13 papers), Immune Cell Function and Interaction (9 papers) and T-cell and B-cell Immunology (8 papers). Jeanne Odom collaborates with scholars based in United States, Malaysia and India. Jeanne Odom's co-authors include Ronald E. Gress, Seth M. Steinberg, Claude Kasten-Sportès, Crystal L. Mackall, Frances T. Hakim, Catherine K. Chow, Barbara A. Vance, Rosemarie Cepeda, Sarfraz Memon and Elizabeth C. Jones and has published in prestigious journals such as The Lancet, Journal of Clinical Investigation and Journal of Clinical Oncology.

In The Last Decade

Jeanne Odom

27 papers receiving 1.1k citations

Peers

Jeanne Odom
Christine E. Codding United States
Jeanne Odom
Citations per year, relative to Jeanne Odom Jeanne Odom (= 1×) peers Christine E. Codding

Countries citing papers authored by Jeanne Odom

Since Specialization
Citations

This map shows the geographic impact of Jeanne Odom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeanne Odom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeanne Odom more than expected).

Fields of papers citing papers by Jeanne Odom

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeanne Odom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeanne Odom. The network helps show where Jeanne Odom may publish in the future.

Co-authorship network of co-authors of Jeanne Odom

This figure shows the co-authorship network connecting the top 25 collaborators of Jeanne Odom. A scholar is included among the top collaborators of Jeanne Odom based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeanne Odom. Jeanne Odom is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fowler, Daniel H., Sattva S. Neelapu, Robert M. Dean, et al.. (2010). EPOCH-F: a novel salvage regimen for multiple myeloma before reduced-intensity allogeneic hematopoietic SCT. Bone Marrow Transplantation. 46(5). 676–681. 5 indexed citations
2.
Pollack, Seth M., Seth M. Steinberg, Jeanne Odom, et al.. (2009). Assessment of the Hematopoietic Cell Transplantation Comorbidity Index in Non-Hodgkin Lymphoma Patients Receiving Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 15(2). 223–230. 33 indexed citations
4.
Bishop, Michael, Robert M. Dean, Seth M. Steinberg, et al.. (2008). Clinical evidence of a graft-versus-lymphoma effect against relapsed diffuse large B-cell lymphoma after allogeneic hematopoietic stem-cell transplantation. Annals of Oncology. 19(11). 1935–1940. 44 indexed citations
5.
Hardy, Nancy M., Frances T. Hakim, Seth M. Steinberg, et al.. (2007). Host T Cells Affect Donor T Cell Engraftment and Graft-versus-Host Disease after Reduced-Intensity Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 13(9). 1022–1030. 7 indexed citations
6.
Hakim, Frances T., Sarfraz Memon, Rosemarie Cepeda, et al.. (2005). Age-dependent incidence, time course, and consequences of thymic renewal in adults. Journal of Clinical Investigation. 115(4). 930–939. 104 indexed citations
7.
Dean, Robert M., Daniel H. Fowler, Wyndham H. Wilson, et al.. (2005). Efficacy of Reduced-Intensity Allogeneic Stem Cell Transplantation in Chemotherapy-Refractory Non-Hodgkin Lymphoma. Biology of Blood and Marrow Transplantation. 11(8). 593–599. 24 indexed citations
8.
Boyiadzis, Michael, Sarfraz Memon, Robert A. Dean, et al.. (2005). Up-Regulation of NK Cell Activating Receptors Associated with Elevated IL-15 Levels Post-Transplant.. Blood. 106(11). 1417–1417. 1 indexed citations
9.
Hakim, Frances T., Sarfraz Memon, Rosemarie Cepeda, et al.. (2005). Age-dependent incidence, time course, and consequences of thymic renewal in adults. Journal of Clinical Investigation. 115(4). 930–939. 268 indexed citations
10.
Fowler, Daniel H., Jason Foley, Jeanne Odom, et al.. (2004). Clinical “cytokine storm” as revealed by monocyte intracellular flow cytometry: correlation of tumor necrosis factor α with severe gut graft-versus-host disease. Clinical Gastroenterology and Hepatology. 2(3). 237–245. 37 indexed citations
11.
Bishop, Michael, Wyndham H. Wilson, Seth M. Steinberg, et al.. (2003). Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas. Biology of Blood and Marrow Transplantation. 9(3). 162–169. 4 indexed citations
12.
Bishop, Michael, Wyndham H. Wilson, Seth M. Steinberg, et al.. (2003). Establishment of early donor engraftment after reduced-intensity allogeneic hematopoietic stem cell transplantation to potentiate the graft-versus-lymphoma effect against refractory lymphomas. Biology of Blood and Marrow Transplantation. 9(3). 162–169. 28 indexed citations
13.
Fowler, Daniel H., Jeannie Hou, Jonathan E. Foley, et al.. (2002). Phase I clinical trial of donor T-helper Type-2 cells after immunoablative, reduced intensity allogeneic PBSC transplant. Cytotherapy. 4(5). 429–430. 12 indexed citations
14.
Welles, Lauri, M. Wayne Saville, Jill Lietzau, et al.. (1998). Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma.. Journal of Clinical Oncology. 16(3). 1112–1121. 127 indexed citations
15.
Saville, M. Wayne, Jill Lietzau, James M. Pluda, et al.. (1995). Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. The Lancet. 346(8966). 26–28. 146 indexed citations
16.
Swan, Kenneth G., et al.. (1994). Surgical prophylaxis for pulmonary embolism.. PubMed. 60(4). 292–5. 46 indexed citations
17.
Odom, Jeanne, et al.. (1993). Primary hyperparathyroidism secondary to parathyroid carcinoma: report of a case.. PubMed. 82(4). 185–7. 1 indexed citations
18.
Odom, Jeanne, et al.. (1991). Splenectomy for minor splenic trauma in patients with HIV infections. Injury. 22(2). 85–86. 1 indexed citations
19.
Thompson, Robert B., Jeanne Odom, & Warren N. Bell. (1965). SPLENOMEGALY, ANEMIA AND THALASSEMIA INTERMEDIA. The American Journal of the Medical Sciences. 250(3). 298–307. 5 indexed citations
20.
Thompson, Robert B., et al.. (1965). Thalassemia with Complete Absence of Hemoglobin A<sub>2</sub> in an Adult. Acta Haematologica. 33(3). 186–190. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026